Takahiro Toda Selected Research

Takahiro Toda Research Topics

Disease

3	Atopic Dermatitis (Atopic Eczema) 01/2019 - 01/2012
3	Diarrhea 05/2013 - 11/2011
3	Polyuria 06/2011 - 01/2010
2	Inflammation (Inflammations) 06/2020 - 11/2015
2	Pruritus (Itching) 01/2019 - 01/2012
2	Obesity 03/2018 - 01/2011
2	Cerebral Hemorrhage 09/2016 - 11/2015
2	Diabetes Mellitus 06/2011 - 01/2010
2	Dehydration (Water Stress) 10/2010 - 01/2010
1	Rheumatoid Arthritis 07/2022
1	Osteoporosis 07/2022
1	Carcinogenesis 06/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2020
1	Reperfusion Injury 01/2019
1	Ischemic Stroke 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Hypertension (High Blood Pressure) 03/2018
1	Cerebral Infarction 09/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Brain Injuries (Brain Injury) 11/2015
1	Chronic Renal Insufficiency 01/2015
1	Graves Disease (Basedow Disease) 05/2013
1	Exophthalmos (Proptosis) 05/2013
1	Hyperthyroidism 05/2013
1	Edema (Dropsy) 05/2013
1	Muscle Weakness 05/2013
1	Rhabdomyolysis 05/2013
1	Thyroid Crisis (Thyrotoxic Crisis) 05/2013
1	Acute Promyelocytic Leukemia 01/2013
1	Neuralgia (Stump Neuralgia) 12/2012
1	Chronic Pain 12/2012
1	Dermatitis 01/2012
1	Fatigue 01/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Body Weight (Weight, Body) 01/2011
1	Type 2 Diabetes Mellitus (MODY) 10/2010
1	Acquired CJD 01/2008
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2008
1	Thalamic Diseases 01/2008

Drug/Important Bio-Agent (IBA)

3	PolyphenolsIBA 03/2018 - 01/2011
2	Messenger RNA (mRNA)IBA 06/2020 - 01/2011
2	Lithium Carbonate (Eskalith)FDA LinkGeneric 06/2011 - 01/2010
2	Streptozocin (Streptozotocin)FDA Link 06/2011 - 01/2010
2	Aquaporin 2IBA 10/2010 - 01/2010
1	GlucocorticoidsIBA 07/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2020
1	AndrogensIBA 06/2020
1	Ergosterol (Lumisterol)IBA 06/2020
1	RNA (Ribonucleic Acid)IBA 06/2020
1	Pregnanolone (Allopregnanolone)IBA 01/2019
1	Ethanol (Ethyl Alcohol)IBA 01/2019
1	NeurosteroidsIBA 01/2019
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 03/2018
1	Hydroxyl RadicalIBA 09/2016
1	EdaravoneIBA 09/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	Heme (Haem)IBA 11/2015
1	HematinicsIBA 01/2015
1	CreatinineIBA 05/2013
1	thyrotropin-binding inhibitory immunoglobulinIBA 05/2013
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 05/2013
1	Phosphotransferases (Kinase)IBA 05/2013
1	ProdrugsIBA 01/2013
1	tamibaroteneIBA 01/2013
1	AcidsIBA 12/2012
1	gamma-Aminobutyric Acid (GABA)IBA 12/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2012
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2012
1	Gabapentin (Neurontin)FDA LinkGeneric 12/2012
1	Pregabalin (Lyrica)FDA Link 12/2012
1	CeramidasesIBA 01/2012
1	Urea (Carbamide)FDA LinkGeneric 01/2012
1	Aquaporins (Water Channels)IBA 01/2012
1	EnzymesIBA 01/2012
1	AmmoniaIBA 01/2012
1	Indomethacin (Indometacin)FDA LinkGeneric 11/2011
1	Prostaglandins EIBA 11/2011
1	Bisacodyl (Bicol)FDA Link 11/2011
1	Therapeutic UsesIBA 06/2011
1	Digoxin (Digitek)FDA LinkGeneric 06/2011
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	Insulin (Novolin)FDA Link 01/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2011
1	Plant ExtractsIBA 01/2011
1	Vasopressins (Vasopressin)IBA 10/2010
1	Codon (Codons)IBA 01/2008

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2016